0000899243-22-026881.txt : 20220727
0000899243-22-026881.hdr.sgml : 20220727
20220727183020
ACCESSION NUMBER: 0000899243-22-026881
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220727
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guerrero Ramiro
CENTRAL INDEX KEY: 0001913253
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 221112249
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-07-27
0
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913253
Guerrero Ramiro
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
0
0
Common Stock
259382
D
Stock Options
1.80
2030-11-14
Common Stock
18000
D
Stock Options
10.00
2031-11-14
Common Stock
18000
D
Warrants
6.00
Common Stock
3579
D
Mr. Guerrero beneficially owns 259,382 shares of common stock.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 12 equal monthly installments beginning on December 15, 2020.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 12 equal monthly installments beginning on November 15, 2021.
Each Warrant became exercisable on the date of issuance of June 29, 2021, and expires on the earliest to occur of: (a) June 28, 2028; or (b) immediately prior to the closing of any change of control of the issuer.
/s/ Ramiro Guerrero
2022-07-27